← All trials
NCT01300975
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2011
- Primary completion
- Jul 1, 2012
- Completion date
- Jul 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 90
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Fundacion Nacional de DermatologiaLead sponsor
- Universidad Mayor San Simón, Cochabamba, Bolivia.Overall official - principal investigator
- Fundacion Nacional de DermatologiaStudy director
- The Alfred Berman Foundation for Medical ResearchCollaborator
- Hospital Dermatológico de JorochitoCollaborator
- Proyecto OSCARCollaborator
- Universidad Mayor San Simón, Cochabamba, Bolivia.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.